Skip to content

Inspection Record

Baxter Corporation — Health Canada Inspection Findings

Health CanadaInspected 2026-07-20 11 findingsAseptic processing and sterility assuranceDeviation, CAPA, and investigationMaterial and supplier controlEquipment and facilityContamination controlOther quality systemCleaning validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

The company did not take precautions to minimize contamination during all processing prior to sterilization.

2Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

3Material and supplier control

The testing or examination of packaging materials was inadequate on a sample received on the premises by a person that packages the drugs.

4Equipment and facility

The design, location, and/or maintenance of the equipment was inadequate for allowing the equipment to serve its intended purpose

5Contamination control

The premises were not designed, constructed, operated, and/or maintained to prevent contamination.

6Other quality system

The recorded information or details were inadequate.

7Other quality system

The company's visual inspection of filled containers was inadequate.

8Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

9Equipment and facility

Critical processes and procedures were not evaluated on a regular basis. Evaluation of production processes, equipment, and/or materials was inadequate.

10Material and supplier control

The handling of raw materials, products, or packaging materials in keeping with pre-approved written procedures or instructions was inadequate.

11Material and supplier control

Each container of a lot of raw materials was not tested to identify its contents with a specific, discriminating test. The sampling plan for raw materials was inadequate.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the Health Canada inspection on 2026-07-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Baxter Corporation findings history — including this company's other documentsAll Health Canada findings Health Canada documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.